Publications:

---

Overview of the Anticancer Potential of the "King of Spices" Piper nigrum and Its Main Constituent Piperine.

Toxins

Turrini, Eleonora E; Sestili, Piero P; Fimognari, Carmela C

Publication Date: 2020-11-26

Variant appearance in text: HER2: A375P

PubMed Link: 33256185

Variant Present in the following documents:

• Main text

View BVdb publication page

---

The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor.

Frontiers In Pharmacology

Wei, Changran C; Li, Xiangqi X

Publication Date: 2020

Variant appearance in text: HER-2: A375P

PubMed Link: 33178014

Variant Present in the following documents:

• Main text
• fphar-11-557429.pdf

View BVdb publication page

---

Stopping transformed cancer cell growth by rigidity sensing.

Nature Materials

Yang, Bo B; Wolfenson, Haguy H; Chung, Vin Yee VY; Nakazawa, Naotaka N; Liu, Shuaimin S; Hu, Junqiang J; Huang, Ruby Yun-Ju RY; Sheetz, Michael P MP

Publication Date: 2020-02

Variant appearance in text: HER2: A375P

PubMed Link: 31659296

Variant Present in the following documents:

• Main text

View BVdb publication page

---

The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.

Bioscience Reports

Kołat, Damian D; Kałuzińska, Żaneta Ż; Bednarek, Andrzej K AK; Płuciennik, Elżbieta E

Publication Date: 2019-03-29

Variant appearance in text: HER2: A375P

PubMed Link: 30824562

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Independent validation of induced overexpression efficiency across 242 experiments shows a success rate of 39.

Scientific Reports

Munkácsy, Gyöngyi G; Herman, Péter P; Győrffy, Balázs B

Publication Date: 2019-01-23

Variant appearance in text: ERBB2: A375P

PubMed Link: 30674897

Variant Present in the following documents:

• 41598_2018_36122_MOESM1_ESM.pdf

View BVdb publication page

---

Single cell polarity in liquid phase facilitates tumour metastasis.

Nature Communications

Lorentzen, Anna A; Becker, Paul F PF; Kosla, Jan J; Saini, Massimo M; Weidele, Kathrin K; Ronchi, Paolo P; Klein, Corinna C; Wolf, Monika J MJ; Geist, Felix F; Seubert, Bastian B; Ringelhan, Marc M; Mihic-Probst, Daniela D; Esser, Knud K; Roblek, Marko M; Kuehne, Felix F; Bianco, Gaia G; O'Connor, Tracy T; Müller, Quentin Q; Schuck, Kathleen K; Lange, Sebastian S; Hartmann, Daniel D; Spaich, Saskia S; Groß, Olaf O; Utikal, Jochen J; Haferkamp, Sebastian S; Sprick, Martin R MR; Damle-Vartak, Amruta A; Hapfelmeier, Alexander A; Hüser, Norbert N; Protzer, Ulrike U; Trumpp, Andreas A; Saur, Dieter D; Vartak, Nachiket N; Klein, Christoph A CA; Polzer, Bernhard B; Borsig, Lubor L; Heikenwalder, Mathias M

Publication Date: 2018-02-28

Variant appearance in text: HER2: A375P

PubMed Link: 29491397

Variant Present in the following documents:

• 41467_2018_Article_3139.pdf

View BVdb publication page

---

Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.

Structure (London, England : 1993)

Harvey, Edward P EP; Seo, Hyuk-Soo HS; Guerra, Rachel M RM; Bird, Gregory H GH; Dhe-Paganon, Sirano S; Walensky, Loren D LD

Publication Date: 2018-01-02

Variant appearance in text: HER2: A375P

PubMed Link: 29276033

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Journal Of Controlled Release : Official Journal Of The Controlled Release Society

Hodgins, Naomi O NO; Al-Jamal, Wafa' T WT; Wang, Julie T-W JT; Klippstein, Rebecca R; Costa, Pedro M PM; Sosabowski, Jane K JK; Marshall, John F JF; Maher, John J; Al-Jamal, Khuloud T KT

Publication Date: 2017-06-28

Variant appearance in text: HER-2: A375P

PubMed Link: 28432037

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells.

Oncogene

Watnick, R S RS; Rodriguez, R K RK; Wang, S S; Blois, A L AL; Rangarajan, A A; Ince, T T; Weinberg, R A RA

Publication Date: 2015-05-28

Variant appearance in text: HER2: A375P

PubMed Link: 25109329

Variant Present in the following documents:

• Main text

View BVdb publication page

---

E47 and Id1 interplay in epithelial-mesenchymal transition.

Plos One

Cubillo, Eva E; Diaz-Lopez, Antonio A; Cuevas, Eva P EP; Moreno-Bueno, Gema G; Peinado, Hector H; Montes, Amalia A; Santos, Vanesa V; Portillo, Francisco F; Cano, Amparo A

Publication Date: 2013

Variant appearance in text: ERBB2: A375P

PubMed Link: 23555842

Variant Present in the following documents:

• Main text

View BVdb publication page

---

The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models.

Plos One

Gril, Brunilde B; Palmieri, Diane D; Qian, Yong Y; Anwar, Talha T; Ileva, Lilia L; Bernardo, Marcelino M; Choyke, Peter P; Liewehr, David J DJ; Steinberg, Seth M SM; Steeg, Patricia S PS

Publication Date: 2011

Variant appearance in text: HER2: A375P

PubMed Link: 21998674

Variant Present in the following documents:

• Main text
• pone.0025625.pdf

View BVdb publication page

---

Thrombopoietin receptor levels in tumor cell lines and primary tumors.

Journal Of Oncology

Erickson-Miller, Connie L CL; Chadderton, Antony A; Gibbard, Anna A; Kirchner, Jennifer J; Pillarisetti, Kodandaram K; Baker, Katherine K; Pandite, Lini L; El-Hariry, Iman I; Mostafa Kamel, Yasser Y; Liu, Yuan Y; Martin, Anne-Marie AM; Messam, Conrad C

Publication Date: 2010

Variant appearance in text: ERBB2: A375P

PubMed Link: 21318160

Variant Present in the following documents:

• 135354.f1.pdf

View BVdb publication page

---